Meet...

Niels Ersbøll

Presenter

Niels Christian Ersbøll is a partner in the EU Antitrust practice, chair of the European Competition practice, and head of the Brussels office. He mainly advises clients on EU competition law in relation to merger control, cartels and restrictive practices, and abuse of dominance, where he has more two decades’ experience. Niels also has significant expertise in advising clients on EU sanctions and export control matters.

He has assisted clients in obtaining merger control clearance on a number of significant transactions before the European Commission and coordinating submissions to competition authorities worldwide for clients such as Pfizer, Boston Scientific and AT&T. He has significant experience assessing filing requirements, devising strategy, dealing with review and designing and negotiating remedies.

In relation to cartels, Niels has successfully acted for companies seeking leniency (immunity as well as fine reductions) before the European Commission, he has appeared before the EU General Court on appeal of European Commission decisions, and is advising on follow-on damage claims. Recently, Niels also has represented individual directors in cartel proceedings, and acted for a whistle blower. He also has significant experience helping clients with designing and implementing compliance measures and conducting internal investigations and audits.

Outside investigations related work, Niels regularly advises clients in relation to, for example, distribution and pricing arrangements, parallel trade, and various forms of cooperation agreements and strategic alliances between competitors. He acts for clients in many industries, and has particular experience within the life sciences, media and the transport & logistics sectors.

As a reflection of his deep understanding of the industry, since the declaration of the Covid-19 pandemic, Niels has also been working extensively with the vaccine industry to advise on a multitude of aspects of vaccine and antiviral procurement by governments and international organisations including the EU, the African Union, COVAX and CARICOM.

Moreover, Niels also regularly advises clients on EU sanctions questions, notably in rapidly changing regulatory environments, especially regarding EU sanctions on Russia. He helps companies establish EU sanctions compliance plans and commercial strategies as well as obtaining authorisations from competent Member States authorities.

Niels Ersbøll’s courses

  • 27 Feb • 1 day course

Competition Law for the Pharmaceutical Industry

Live online

  • 20 May • 2 day course

Drafting Commercial Contracts for the Pharmaceutical Industry

Live online, Classroom

Reviews for Niels ’s courses

A good concentrated overview of the topic of drafting pharma contracts which is normal for a 2 day course in the subject. I enjoyed the overall experience.

12 Nov 2025

Drafting Commercial Contracts for the Pharmaceutical Industry

I was hoping to have a detailed analysis of all the aspects a legal who works in a pharmaceutical company may encounter and how to deal with it. I must say the webinar was very beyond my expectations and I definitely accomplished my goal (and more!). I am in the pharmaceutical industry just from 2022, and this two days helped me a lot.

12 Nov 2025

Drafting Commercial Contracts for the Pharmaceutical Industry

My vote is definitely a 10/10: the webinar dealt with all the topics (and more..) I wanted to explore, as I work with it every day. I liked a lot also all the PPT presentations. All speakers were excellent, and the way of explaining very clear and prepared. I found the topics very engaging.

12 Nov 2025

Drafting Commercial Contracts for the Pharmaceutical Industry

I hoped to improve my knowledge in the field of in-licensing and out-licensing agreements. I am completely satisfied. I got answers to my questions, structured my knowledge, received new, previously unknown to me information Everything was great.

21 May 2025

Drafting Commercial Contracts for the Pharmaceutical Industry

Very concentrated and structured content. All speakers had high level expertise on the topics presented. Useful for in-house practitioners (lawyers, BD) in the pharmaceutical industry as a guide to the main topics in contract drafting. I have expanded my knowledge [on] license agreement issues, IP issues, Co-development agreements.

21 May 2025

Drafting Commercial Contracts for the Pharmaceutical Industry

All the speakers were excellent, highly prepared, and professional. Thank You for the valuable training

20 Nov 2024

Drafting Commercial Contracts for the Pharmaceutical Industry

Extremely valuable insights. The webinar successfully met [all of] my goals. The session offered valuable practical insights that enhanced my knowledge overall. It was a highly beneficial learning experience.

20 Nov 2024

Drafting Commercial Contracts for the Pharmaceutical Industry

Everything was perfect. Great webinar that summarizes important points in pharma business negotiations.

20 Nov 2024

Drafting Commercial Contracts for the Pharmaceutical Industry

Great seminar, support was exceptional, I am very happy, top class presentations, top class speakers!

20 Nov 2024

Drafting Commercial Contracts for the Pharmaceutical Industry

Definitely worth the price!

8 Jul 2024

Drafting Commercial Contracts for the Pharmaceutical Industry